1-(3-chlorophenyl)piperazine has been researched along with Perceptual Disorders in 1 studies
1-(3-chlorophenyl)piperazine: supposed metabolite of TRAZODONE; RN given refers to parent cpd; structure
1-(3-chlorophenyl)piperazine : A N-arylpiperazine that is piperazine carrying a 3-chlorophenyl substituent at position 1. It is a metabolite of the antidepressant drug trazodone.
Perceptual Disorders: Cognitive disorders characterized by an impaired ability to perceive the nature of objects or concepts through use of the sense organs. These include spatial neglect syndromes, where an individual does not attend to visual, auditory, or sensory stimuli presented from one side of the body.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| D'Souza, DC | 1 |
| Gil, RB | 1 |
| Zuzarte, E | 1 |
| MacDougall, LM | 1 |
| Donahue, L | 1 |
| Ebersole, JS | 1 |
| Boutros, NN | 1 |
| Cooper, T | 1 |
| Seibyl, J | 1 |
| Krystal, JH | 1 |
1 trial available for 1-(3-chlorophenyl)piperazine and Perceptual Disorders
| Article | Year |
|---|---|
gamma-Aminobutyric acid-serotonin interactions in healthy men: implications for network models of psychosis and dissociation.
Topics: Analysis of Variance; Anxiety; Cross-Over Studies; Dissociative Disorders; Double-Blind Method; Drug | 2006 |